Bioactive lipids in antiviral immunity

A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes

(2020) Colin D. Funk et al.   Frontiers in Pharmacology

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

(2020) Christine Toelzer et al.   SCIENCE

Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death

(2019) Valerie B. O’Donnell et al.   Science Signaling

Leukotriene B4–type I interferon axis regulates macrophage-mediated disease tolerance to influenza infection

(2019) Erwan Pernet et al.   Nature Microbiology

Virus Impact on Lipids and Membranes

(2019) Ellen Ketter et al.   Annual Review of Virology

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

(2019) Andreane Cartier et al.   SCIENCE

PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN- λ production

(2018) Rhiannon B. Werder et al.   Science Translational Medicine

Prostaglandin E2-mediated impairment of innate immune response to A(H1N1)pdm09 infection in diet-induced obese mice could be restored by paracetamol

(2018) Anna J X Zhang et al.   JOURNAL OF INFECTIOUS DISEASES

Targeted Prostaglandin E2 Inhibition Enhances Antiviral Immunity through Induction of Type I Interferon and Apoptosis in Macrophages

(2014) François Coulombe et al.   IMMUNITY

Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice

(2011) Jincun Zhao et al.   JOURNAL OF CLINICAL INVESTIGATION

Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

(2008) Yumiko Imai et al.   CELL